PELO
Basic information
Region (hg38): 5:52787916-52804044
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PELO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 18 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 20 | 0 | 0 |
Variants in PELO
This is a list of pathogenic ClinVar variants found in the PELO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-52788369-C-A | not specified | Uncertain significance (Aug 28, 2023) | ||
5-52788402-T-C | not specified | Uncertain significance (Jul 20, 2022) | ||
5-52800432-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
5-52800570-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
5-52800576-T-C | not specified | Uncertain significance (Apr 27, 2023) | ||
5-52800672-A-T | not specified | Uncertain significance (Mar 15, 2024) | ||
5-52800812-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
5-52800873-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
5-52800902-A-C | not specified | Uncertain significance (Aug 08, 2022) | ||
5-52800915-A-C | not specified | Uncertain significance (Dec 15, 2023) | ||
5-52800969-C-A | not specified | Uncertain significance (Feb 15, 2023) | ||
5-52800971-A-G | not specified | Uncertain significance (Jun 21, 2022) | ||
5-52801476-G-T | not specified | Uncertain significance (Jan 23, 2023) | ||
5-52801510-A-T | not specified | Uncertain significance (Sep 06, 2022) | ||
5-52801525-C-G | not specified | Uncertain significance (Jan 31, 2024) | ||
5-52801532-A-G | not specified | Uncertain significance (Aug 30, 2022) | ||
5-52801594-A-C | not specified | Uncertain significance (Apr 12, 2023) | ||
5-52801668-A-G | not specified | Uncertain significance (Jan 11, 2023) | ||
5-52801679-G-C | not specified | Uncertain significance (Jun 17, 2022) | ||
5-52801709-G-C | not specified | Uncertain significance (Nov 21, 2023) | ||
5-52801763-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
5-52801776-T-G | not specified | Uncertain significance (Apr 16, 2024) | ||
5-52801802-T-C | not specified | Uncertain significance (Mar 18, 2024) | ||
5-52801814-G-A | not specified | Uncertain significance (May 21, 2024) | ||
5-52801835-G-C | not specified | Uncertain significance (May 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PELO | protein_coding | protein_coding | ENST00000274311 | 2 | 16107 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0105 | 0.950 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.641 | 196 | 223 | 0.879 | 0.0000105 | 2549 |
Missense in Polyphen | 51 | 77.582 | 0.65737 | 870 | ||
Synonymous | 0.411 | 84 | 88.9 | 0.945 | 0.00000414 | 772 |
Loss of Function | 1.79 | 5 | 11.6 | 0.433 | 5.35e-7 | 131 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000149 | 0.000149 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000794 | 0.0000791 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000262 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for normal chromosome segregation during cell division and genomic stability (By similarity). May function in recognizing stalled ribosomes and triggering endonucleolytic cleavage of the mRNA, a mechanism to release non-functional ribosomes and degrade damaged mRNAs. May have ribonuclease activity (Potential). {ECO:0000250, ECO:0000305}.;
- Pathway
- mRNA surveillance pathway - Homo sapiens (human);Focal Adhesion-PI3K-Akt-mTOR-signaling pathway
(Consensus)
Intolerance Scores
- loftool
- 0.472
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.75
Haploinsufficiency Scores
- pHI
- 0.366
- hipred
- Y
- hipred_score
- 0.629
- ghis
- 0.491
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pelo
- Phenotype
- growth/size/body region phenotype; cellular phenotype; embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- cell cycle;endoderm development;cell population proliferation;stem cell population maintenance;positive regulation of BMP signaling pathway;ribosome disassembly;chromosome organization;cell division;mesenchymal to epithelial transition;nuclear-transcribed mRNA catabolic process, non-stop decay;nonfunctional rRNA decay;nuclear-transcribed mRNA catabolic process, no-go decay;RNA surveillance;nucleic acid phosphodiester bond hydrolysis
- Cellular component
- nucleus;cytoplasm
- Molecular function
- endonuclease activity;protein binding;ribosome binding;metal ion binding